Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 122194-07-4 | MDL No. : | MFCD00153505 |
Formula : | C8H20NO2P | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KXUMNSXPAYCKPR-UHFFFAOYSA-N |
M.W : | 193.22 | Pubchem ID : | 5171659 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 53.61 |
TPSA : | 35.29 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.16 cm/s |
Log Po/w (iLOGP) : | 2.9 |
Log Po/w (XLOGP3) : | 1.86 |
Log Po/w (WLOGP) : | 2.62 |
Log Po/w (MLOGP) : | 1.22 |
Log Po/w (SILICOS-IT) : | 1.03 |
Consensus Log Po/w : | 1.93 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.88 |
Solubility : | 2.55 mg/ml ; 0.0132 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.22 |
Solubility : | 1.16 mg/ml ; 0.00599 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.23 |
Solubility : | 11.3 mg/ml ; 0.0586 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With triethylamine In tetrahydrofuran for 0.333333 h; Inert atmosphere; Cooling with ice | Synthesis of 3-9, the resulting yellow solution was spin evaporated directly added triethylamine 47mL (325mmol, 32.9g), 250mL of tetrahydrofuran and stirred to give a yellow suspension. In the dropping funnel was added anhydrous methanol 13mL (322mmol, 10.3g), nitrogen ice-salt bath was added dropwise methanol within 20min, 150mL of tetrahydrofuran wash dropping funnel. After dropping to give a white suspension. The ice bath was removed, stirred for 2h, allowed to stand for a few minutes, filtered off with suction to obtain yellow liquid with a pale pink solid. Wash a small amount of tetrahydrofuran solid. Tetrahydrofuran was removed by rotary evaporation. 5percent sodium bicarbonate was poured into 10mL, 20mL and extracted three times with dichloromethane and the combined organic phase, methylene chloride was removed by rotary evaporation, distillation under reduced pressure pumps, taking 78 stable fraction. To give a colorless liquid and a white solid within a condenser tube, identified as the same substance, the collection can be combined, yield 16.68 g, 42percent yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With triethylamine; In tetrahydrofuran; for 0.333333h;Inert atmosphere; Cooling with ice; | Synthesis of 3-9, the resulting yellow solution was spin evaporated directly added triethylamine 47mL (325mmol, 32.9g), 250mL of tetrahydrofuran and stirred to give a yellow suspension. In the dropping funnel was added anhydrous methanol 13mL (322mmol, 10.3g), nitrogen ice-salt bath was added dropwise methanol within 20min, 150mL of tetrahydrofuran wash dropping funnel. After dropping to give a white suspension. The ice bath was removed, stirred for 2h, allowed to stand for a few minutes, filtered off with suction to obtain yellow liquid with a pale pink solid. Wash a small amount of tetrahydrofuran solid. Tetrahydrofuran was removed by rotary evaporation. 5% sodium bicarbonate was poured into 10mL, 20mL and extracted three times with dichloromethane and the combined organic phase, methylene chloride was removed by rotary evaporation, distillation under reduced pressure pumps, taking 78 stable fraction. To give a colorless liquid and a white solid within a condenser tube, identified as the same substance, the collection can be combined, yield 16.68 g, 42% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4,5-dichloroimidazole; In dichloromethane; at 20℃; for 1.75h; | A mixture of 2, 3,4, 6-tetra-D-benzyl-D-mannose (Koto et al., 1976) (940 mg, 1.74 mmol), dimethoxy-N, N-diisopropylphosphoromidate (437 mg, 2.27 mmol) and 4,5-dichloroimidazole (355 mg, 2.61 mmol) in dry dichloromethane (25 mL), under nitrogen, was stirred at room temperature for 105 min. The mixture was poured into water (100 mL) and extracted with dichloromethane. The organic layer was washed with water, dried over magnesium sulfate and the solvent was removed. The residue consisting mainly of phosphite 10 was used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | A solution of tetrazole in CH3CN (0.45 M, 4.6 ml, 2.07 mmol) was added to a solution of (all-2)-5,8,ll,14,17-eicosapentaen-l-ol (181 mg, 0.63 mmol) and .dimethyl iV^V-diisopropylphosphoramidite (215 mul, 1.00 mmol) in dry CH2Cl2 (15 ml). After 50 minutes of stirring at room temperature under N2-atmosphere the mixture was cooled to 0 C and 50% H2O2 (75 mul) was added. The mixture was stirred <n="33"/>for 75 minutes, diluted with CH2Cl2 (50 ml) and washed with 10 % Na2S2O5 (20 ml x 2), sat. NaHCO3 (aq) (20 ml x 2), water (20 ml), brine (20 ml), dried (Na2SO4) and evaporated in vacuo. Flash chromatography on silica gel eluting with heptane - heptanerEtOAc (1:1) yielded 167 mg (67%) of the title compound as a colorless liquid.[0112] 1H NMR (200 MHz, CDCl3) delta 0.95 (t, J=7.5 Hz, 3H), 1.36-1.51 (m, 2H), 1.61-1.80 (m, 2H), 1.98-2.13 (m, 4H), 2.76-2.84 (m, 8H), 3.74 (d, J=I l Hz, 6H), 4.03 (q, J=6.7 Hz, 2H), 5.22-5.43 (m, 10H); MS (ESI); 419 [M+Na+]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1H-Tetrazole (0.48 g, 6.8 mmol) was added to a solution of the reducingsugar S3 (3.1 g, 5.7 mmol) and i-Pr2NP(OMe)2 (1.6mL, 6.8 mmol) in dry CH2Cl2 (25 mL) at 0 C. The mixturewas stirred for 5 min and warmed to rt. After being stirred for 5 min, i-Pr2NP(OMe)2 (0.10mL, 0.43 mmol) was added to the solution. The reaction was quenched with asaturated NaHCO3 aqueous solution (40 mL) after 30 min. The mixturewas extracted with CH2Cl2 (200 mL) and the organic layerwas washed with saturated NaHCO3 aqueous solutions (3 × 200 mL). Theaqueous layer was then back-extracted with CH2Cl2 (200 mL).The combined organic layers were dried over Na2SO4,filtered and concentrated under reduced pressure. The residue was dissolved in freshlydistilled THF (23 mL) and a solution of BH3?THF (0.99 M, 17 mL, 17mmol) in THF was added to the solution at 0 C. The reaction mixture wasstirred for 5 min and warmed to rt. After being stirred for 12 h, the mixturewas concentrated under reduced pressure. The residue was dissolved in CHCl3(150 mL) and successively washed with saturated NaHCO3 aqueoussolutions (2 × 150 mL) and a brine (150 mL). The aqueous layer wasback-extracted with CHCl3 (150 mL). The combined organic layers weredried over Na2SO4, filterd and concentrated under reducedpressure. Purification of the residue by silica gel column chromatography[hexane-AcOEt (7:1, v/v)] gave 7 as a colorless syrup (3.5 g, 5.4mmol, 97%, a/b = 67:33). The 1H and 31PNMR spectra were in good agrrement with the reported data.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1H-Tetrazole (0.25 g, 3.6 mmol) was addedto a solution of the reducing sugar S5 (1.6g, 3.0 mmol) and i-Pr2NP(OMe)2(0.55 mL, 2.4 mmol) in dry CH2Cl2 (6.0 mL) at 0 C. Themixture was stirred for 5 min and warmed to rt. After being stirred for 45 min,the reaction was quenched with a saturated NaHCO3 aqueous solution(12 mL). The mixture was extracted with CH2Cl2 (100 mL)and the organic layer was washed with saturated NaHCO3 aqueoussolutions (3 × 100 mL). The aqueous layer was then back-extracted with CH2Cl2(100 mL). The combined organic layers were dried over Na2SO4,filtered and concentrated under reduced pressure. The residue was dissolved in freshlydistilled THF (15 mL) and a solution of BH3?THF (0.99 M, 9.0 mL, 8.9mmol) was added to the solution at 0 C. The reaction mixture was stirred for 5min and warmed to rt. After being stirred for 4.5 h, the mixture was concentratedunder reduced pressure. The residue was then dissolved in CHCl3 (100mL) and successively washed with saturated NaHCO3 aqueous solutions(2 × 100 mL) and a brine (100 mL). The aqueous layer was back-extracted withCHCl3 (100 mL). The combined organic layers were dried over Na2SO4,filterd and concentrated under reduced pressure. Purification of the residue bysilica gel column chromatography [hexane-AcOEt (7:1, v/v)] gave8 (1.6 g, 2.4 mmol, quant, a:b = 90:10) as a colorless syrup. The 1Hand 31P NMR spectra were in good agrrement with the reported data.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1H-Tetrazole (0.34 g, 4.8 mmol) was added to a solution of the reducingsugar S1 (2.2 g, 4.0mmol) and i-Pr2NP(OMe)2(1.0 mL, 4.4 mmol) in dry CH2Cl2 (12 mL) at 0 C. Themixture was stirred for 5 min and then warmed to rt. Dry CH2Cl2(4.0 mL) was added twice every 12 min to dissolve 1H-tetrazole and the mixture was stirred for 10 min. Additional 1H-tetrazole (0.34 g, 4.8 mmol) was then addedto the mixture. After being stirred for 10 min, i-Pr2NP(OMe)2 (0.70 mL, 3.1 mmol) was addedto the solution, and the reaction was quenched with a saturated NaHCO3aqueous solution (20 mL) 30 min later. The mixture was extracted with CH2Cl2(200 mL) and then the organic layer was washed with saturated NaHCO3aqueous solutions (3 × 200 mL), dried over Na2SO4,filtered and concentrated under reduced pressure. The residue was dissolved in freshlydistilled THF (20 mL) and a solution of BH3?THF (0.99 M, 12 mL, 12mmol) in THF was added to the solution at 0 C. The reaction mixture wasstirred for 5 min and warmed to rt. The reaction mixture was then stirred for30 min and concentrated under reduced pressure. The residue was dissolved inCHCl3 (200 mL) and washed successively with saturated NaHCO3aqueous solutions (2 × 200 mL) and with a mixture of brine (100 mL) and asaturated NaHCO3 aqueous solution (100 mL). The aqueous layer wasback-extracted with CHCl3 (100 mL). The combined organic layers weredried over Na2SO4, filterd and concentrated under reducedpressure. Purification of the residue by silica gel column chromatography[hexane-AcOEt (6:1 to 4:1, v/v)] gave 1 as a colorless syrup (2.5 g, 3.9 mmol,96%, a/b = 74:26). The 1H and 31PNMR spectra were in good agrrement with reported data.1 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
To a solution of diol 7 (904 mg, 1.16 mmol) and phosphoramidite 13 3 (1.34 g, 6.96 mmol) in CH2Cl2 (10 mL) was added 1H-tetrazole (188 mg, 6.96 mmol) at room temperature. The reaction was stirred at room temperature for 2 h, and then cooled to 0 C. To the cooled solution was added mCPBA (1.20g, 6.96 mmol), and the resulting mixture was stirred at the same temperature. After being stirred for 30 min, the reaction was quenched with sat. aq. NaHCO3. The mixture was extracted three times with AcOEt. The combined organic extracts were washed with brine, dried over Na2SO4, and concentrated in vacuo. Purification of the residue by flash chromatography (acetone/hexane, 1:2) gave crude 3,5-bisphosphorylated product as a yellow oil. To a cooled (0 C) solution of the crude product in THF (11.6 mL) was added TBAF (1.0 M solution in THF, 3.48 mL, 3.48 mmol). After being stirred at the same temperature for 3 h, the reaction was quenched with water. The mixture was extracted three times with AcOEt. The combined organic extracts ware washed with brine, dried over MgSO4, and concentrated in vacuo. Purification of the residue by flash chromatography (acetone/hexane, 1:2 to 2:1) gave 764 mg (1.01 mmol 87%) of alcohol 15 as a colorless glassy solid. 15: [alpha]D26 -24.4 (c 1.7, CHCl3); IR (neat) 3389, 2955, 1454 cm-1; 1H-NMR (400 MHz, CDCl3) delta 7.39-7.26 (15H, m), 5.03-4.96 (4H, m), 4.88 (1H, d, J = 6.8 Hz), 4.83-4.79 (3H, m), 4.73-4.59 (4H, m), 4.37 (1H, brs), 4.34-4.26 (1H, m), 4.24-4.22 (2H, m), 4.16 (1H, d, J = 4.0 Hz), 3.82 (1H, t, J = 9.4 Hz), 3.78-3.69 (12H, m), 3.57 (1H, dt, J = 2.8, 9.4 Hz); 13C-NMR (100 MHz, CDCl3) delta 138.0, 137.5, 136.8, 128.5, 128.2, 127.95, 127.94, 127.89, 127.63, 127.57, 127.50, 96.7, 96.1, 96.0, 82.4, 79.9, 74.9, 70.5, 70.2, 69.9, 54.6-54.3; 31P-NMR (243 MHz, CDCl3) delta 1.62, 1.58; LRMS (ESI) m/z 779 [(M++Na)]; HRMS calcd for C34H46O15NaP2 779.2204 (M++Na), found 779.2190. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | The 75mg (0.348mmol)iPr2NP (OCH3)2And 24mg (0.348mmol) was dissolved in 10mL CH2Cl2, tetrazole Was stirred under nitrogen for 30min, was added 48mg 10mL CH2Cl (0.087mmol) of 3-17 Solution was stirred overnight at room temperature, 12h after addition of 88mg (0.348 mmol) m-CPBA under ice-cooling, to room temperature naturally. Water was added and extracted, oil with 10% (w / v) sodium sulfite solution three times, washed three times with saturated sodium bicarbonate, washed once with water, dried over anhydrous magnesium sulfate, and separated by column chromatography (petroleum ether: ethyl acetate: methanol = 1: 0.06) to give an oil 51mg, yield 76% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | The 255mg (1.224mmol) i-Pr 2NP (OCH 3) 2And 87mg (1.224mmol) was dissolved in 10 mL CH2Cl 2 tetrazole Was stirred under nitrogen for 30min, was added 98mg 5mL CH2Cl2 (0.136mmol) of 3-18 Solution was stirred overnight at room temperature, 12h after addition of 335mg (1.224mmol) m-CPBA under ice-cooling, to room temperature naturally. Water was added and extracted, oil with 10% (w / v) sodium sulfite solution three times, washed three times with saturated sodium bicarbonate, washed once with water, dried over anhydrous magnesium sulfate, and separated by column chromatography (petroleum ether: ethyl acetate: methanol = 1: 1:0.15) to give an oil 140mg, yield 99% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | 46 mg (0.2 mmol) of i-Pr2NP (OCH3) 2 and16 mg (0.5 mmol) was dissolved in 10 mL CH2CI2,Stirring under the pressure of 30min, adding 68mg (0. lmmol) 3-22, stirring at room temperature overnight,After 12 h, 51 mg (0. l mmol) of m-CPBA was added under ice-water bath condition,Naturally returned to room temperature. Add water extraction, the oil layer with 10% (w / v) sodium sulfite solution washed three times,Saturated with sodium bicarbonate three times, washed once, anhydrous magnesium sulfate dry,Column chromatography (petroleum ether: ethyl acetate = 1: 2) gave an oil 60 mg in 80% yield,(Rf = 0.1, petroleum ether: ethyl acetate = 1: 2) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetra-(n-butyl)ammonium iodide; In dichloromethane; at 20℃; for 0.5h; | Dimethyl N,N-diisopropylphosphoramidite (181 muL; 0.786 mmol) was added to a stirred suspension of 21a (100 mg; 0.262 mmol) and tetrabutylammonium iodide (97 mg; 0.262 mmol) in dry CH2Cl2 (4 mL). The reaction mixture, which quickly turned into a light-brown clear solution, was stirred at rt for 30 min. The mixture was evaporated to dryness, and the leuco dye was isolated by column chromatography (18 g SiO2, gradient 50% to 100% EtOAc/hexane) and used directly in the next step. The material was dissolved in CH2Cl2 (3 mL), the solution was cooled in dry ice-acetone bath, and DDQ (59 mg; 0.26 mmol) in CH2Cl2 (3 mL) was added quickly dropwise. The resulting turquoise-blue solution was allowed to warm up to rt, stirred for 15 min. The mixture was evaporated to dryness, and the residue was subjected to column chromatography (20 g of SiO2, gradient 0% to 5% H2O/MeCN, then 5% H2O/MeCN+0.5 v/v % TFA); the fractions containing the product were pooled and evaporated. The residue was dissolved in 1,4-dioxane (with addition of minimal amount of water to dissolve the solids), centrifuged, the supernatant was filtered through 0.2 muM PTFE membrane filter and lyophilized. Blue solid, yield 145 mg (97%). MS (ESI): m/z (positive mode, rel. int., %)=460.2 (100) [M]+. HRMS (C24H35N3O2PS): m/z (positive mode)=460.2184 (found [M]+), 460.2182 (calc.). UV/Vis (MeCN): lambdamax (epsilon)=654 nm (64000 M-1cm-1); fluorescence (MeCN): lambdaexcit=610 nm, lambdaem=728 nm, phifl=0.10. Standard: Oxazine 1, phifl=0.11 (EtOH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With tetra-(n-butyl)ammonium iodide; In dichloromethane; acetonitrile; at 20℃; for 0.333333h; | Dimethyl N,N-diisopropylphosphoramidite (84 muL, 0.366 mmol) was added to a solution of 3,7-bis(dimethylamino)-5,5-dimethyl-5,10-dihydrodibenzo[b,e]silinylium perchlorate [Koide, Y.; Urano, Y.; Hanaoka, K.; Terai, T.; Nagano, T. ACS Chem. Biol. 2011, 6(14), 600-608] (50 mg, 0.122 mmol) and tetrabutylammonium iodide (45 mg, 0.122 mmol) in MeCN (2 mL) and CH2Cl2 (2 mL), and the resulting mixture was stirred at rt for 20 min. The clear colorless solution was evaporated to dryness and the product was isolated by column chromatography (25 g of SiO2, gradient 33% to 50% EtOAc/hexane). The fraction containing the product were pooled, evaporated and dried in vacuo to yield 55 mg (92%) of the leuco dye as a viscous colorless oil. 1H NMR (400 MHz, CD3CN): delta 7.18 (ddd, J=8.6, 3.7, 2.5 Hz, 2H), 6.97 (dd, J=16.1, 2.9 Hz, 2H), 6.73 (dddd, J=11.4, 8.5, 3.0, 0.9 Hz, 2H), 4.49 (d, J=24.2 Hz, 1H), 3.41 (dp, J=17.6, 6.7 Hz, 2H), 3.16 (d, J=10.6 Hz, 3H), 2.92 (s, 6H), 2.90 (s, 6H), 1.17 (d, J=6.6 Hz, 6H), 0.93 (d, J=6.7 Hz, 6H), 0.61 (s, 3H), 0.37 (s, 3H) ppm. 13C NMR (101 MHz, CD3CN): delta 150.1 (d, J=3.0 Hz), 149.8 (d, J=2.9 Hz), 138.3 (d, J=4.8 Hz), 137.8 (d, J=4.6 Hz), 132.5 (d, J=8.5 Hz), 132.1 (d, J=5.4 Hz), 131.5 (d, J=6.9 Hz), 118.7 (d, J=3.4 Hz), 118.1 (d, J=3.2 Hz), 114.3 (d, J=3.0 Hz), 113.8 (d, J=3.3 Hz), 52.1 (d, J=120.9 Hz), 51.2 (d, J=7.6 Hz), 46.7 (d, J=3.6 Hz), 41.0 (d, J=1.1 Hz), 24.2, 22.6 (d, J=2.3 Hz), 0.2 (d, J=1.0 Hz), -0.1 (d, J=4.2 Hz) ppm. 31P NMR (162 MHz, CD3CN): delta 31.20 ppm. MS (ESI): m/z (positive mode, rel. int., %)=488.3 (100) [M+H]+. HRMS (C26H42N3O2PSi): m/z (positive mode)=488.2860 (found [M+H]+), 488.2857 (calc.). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetra-(n-butyl)ammonium iodide; In dichloromethane; at 20℃; for 0.5h; | Dimethyl N,N-diisopropylphosphoramidite (172 muL; 0.75 mmol) was added to a stirred solution of 28d (100 mg; 0.25 mmol) and tetrabutylammonium iodide (92 mg; 0.25 mmol) in dry CH2Cl2 (5 mL). The vial was flushed with argon and the blue suspension was stirred at RT for 30 min, turning into a clear brown solution. The mixture was evaporated to dryness, and the intermediate 7H-benz[de]anthracene adduct was isolated by column chromatography (25 g of SiO2, gradient 50% to 100% EtOAc2/hexane). The compound was used immediately in the next step. The material was dissolved in CH2Cl2 (10 mL), the solution was cooled in dry ice-acetone bath, and DDQ (57 mg; 0.105 mmol) in CH2Cl2 (3 mL) was added quickly dropwise. The resulting blue-green solution was allowed to warm up to RT, stirred for 15 min, followed by addition of trifluoroacetic acid (100 muL). The mixture was evaporated to dryness, and the residue was subjected to column chromatography (35 g of SiO2, gradient 0% to 50% H2O/MeCN); the fractions containing the product were pooled, trifluoroacetic acid (200 muL) was added, MeCN was evaporated (bath temperature ?25 C.) and the aqueous solution was freeze-dried. The residue was dissolved in 1,4-dioxane (with addition of minimal amount of water to dissolve the solids), filtered through 0.2 muM PTFE membrane filter and re-lyophilized. Blue solid, yield 88 mg (61%). 1H NMR (400 MHz, CD3OD): delta 9.49 (d, J=10.3 Hz, 1H), 9.35 (d, J=8.2 Hz, 1H), 9.19 (d, J=9.8 Hz, 1H), 8.73 (d, J=7.9 Hz, 1H), 8.06 (t, J=8.0 Hz, 1H), 8.01 (t, J=2.0 Hz, 1H), 7.58 (d, J=10.3 Hz, 1H), 7.41 (dd, J=9.8, 2.7 Hz, 1H), 4.99 (d, J=1.7 Hz, 6H), 3.85 (s, 6H), 3.68 (d, J=11.5 Hz, 2H), 3.34 (s, 3H), 1.35 (dd, J=6.8, 3.2 Hz, 12H) ppm. 19F NMR (376 MHz, CD3OD): delta -77.29 ppm. 13C NMR (101 MHz, CD3OD): delta 165.9, 153.6, 143.1 (d, J=4.9 Hz), 138.9 (d, J=152.9 Hz), 137.8 (d, J=11.5 Hz), 135.3, 133.4 (d, J=4.2 Hz), 132.5, 131.4 (d, J=2.4 Hz), 128.3, 127.9 (d, J=13.7 Hz), 126.3 (d, J=9.4 Hz), 125.3 (d, J=9.1 Hz), 124.0 (d, J=1.2 Hz), 104.4 (d, J=1.2 Hz), 52.9 (d, J=5.9 Hz), 48.7 (d, J=5.8 Hz), 46.7, 40.5, 23.2 (d, J=2.8 Hz), 22.8 (d, J=2.8 Hz) ppm. 31P NMR (162 MHz, CD3OD): delta 25.95 ppm. MS (ESI): m/z (positive mode, rel. int., %)=478.3 (100) [M]+. HRMS (C28H32N3O2P): m/z (positive mode)=478.2621 (found [M]+), 478.2618 (calc.). UV/Vis (PBS 7.4): lambdamax (epsilon)=644 nm (7600 M-1cm-1); fluorescence (PBS 7.4): lambdaexcit=580 nm, lambdaem=782 nm, CDfl=0.04. Standard: Atto 594, phifl=0.85 (H2O). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In acetonitrile; at 60℃; for 0.5h;Inert atmosphere; | In a screw-cap test tube to a suspension of Pyronin Y (50 mg; 0.165 mmol) in MeCN (1 mL) <strong>[122194-07-4]dimethyl N,N-diisopropylphosphoramidite</strong> (32 mg; 0.165 mmol) was added at r.t. under Ar. The reaction mixture was warmed up to 60 C. and stirred for 30 min at this temperature. After cooling down to 0 C., DDQ (37 mg; 0.165 mmol) was added, and the reaction mixture was stirred for additional 10 min at 0 C. After warming up to r.t., the reaction mixture was directly subjected to column chromatography on SiO2 (30 g; MeCN?MeCN/H2O 20:1+0.1 v/v % of TFA). Fractions containing the title compound were evaporated to dryness, dissolved in water and extracted with CH2Cl2 (3*). The combined extracts were dried with Na2SO4 and evaporated to yield 32 mg (40%) of a dark violet solid. 1H NMR (400 MHz, CD3CN): delta=1.23 (d, JH-H=6.8 Hz, 6H, NiPr2), 1.26 (d, JH-H=6.8 Hz, 6H, NiPr2), 3.29 (s, 12H, 2*NMe2), 3.44-3.60 (m, 2H, NiPr2), 3.72 (d, JH-P=11.5 Hz, 3H, OMe), 6.74-6.77 (m, 2Har), 7.15 (dd, JH-H=9.9 and 2.7 Hz, 2Har), 8.89 (d, JH-H=9.9 Hz, 2Har) ppm. 13C NMR (100 MHz, CD3CN, APT): delta=18.1 (+), 21.8 (+, d, JC-P=2.7 Hz), 21.9 (+, d, JC-P=2.7 Hz), 47.0 (+, m), 52.0 (+, d, JC-P=5.8 Hz), 96.2 (+), 114.7 (+), 116.0 (-, d, JC-P=9.2 Hz), 132.2 (+, d, JC-P=3.3 Hz), 156.9 (-), 157.4 (-, d, JC-P=11.7 Hz) ppm. 31P NMR (162 MHz, CD3CN): delta=20.1 ppm. MS (ESI): m/z (positive mode, rel. int., %)=444.4 (100) [M-Cl]+. HPLC: tR=13.1 min (91%), B/A=30/70-100/0 in 25 min, column 4*250 mm, 1.2 mL/min, detection at 254 nm. UV/Vis (MeCN): lambdamax (epsilon)=616 nm (52455 M-1cm-1); fluorescence (MeCN): lambdaexcit=590 nm, lambdaem=649 nm, phifl=0.39. Standard: Oxazine 4, phifl=0.63 (MeOH). UV/Vis (PBS 7.4): lambdamax (epsilon)=628 nm (46051 M-1cm-1); fluorescence (PBS 7.4): lambdaexcit=590 nm, lambdaem=664 nm, phifl=0.11. Standard: Oxazine 4, phifl=0.63 (MeOH). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In a screw-cap test tube to a suspension of the corresponding pyronine (50 mg; 0.13 mmol) in MeCN (1 mL) <strong>[122194-07-4]dimethyl N,N-diisopropylphosphoramidite</strong> (100 mg; 0.52 mmol) was added at r.t. under Ar. The resulting reaction mixture was warmed up to 60 C. and stirred for 2.5 h at this temperature. After cooling down to 0 C., DDQ (116 mg; 0.52 mmol) was added, and the reaction mixture was stirred for additional 10 min at 0 C. After warming up to r.t., the reaction mixture was diluted with MeCN (10 ml) and directly subjected to column chromatography on SiO2 (100 g; MeCN?MeCN/H2O 20:1+0.1 v/v % of TFA). Fractions containing the title compound were evaporated to dryness, dissolved in water and extracted with CH2Cl2 (3*). Combined organic solutions were dried with Na2SO4 and evaporated to yield 40 mg of a dark blue solid. HPLC analysis (B/A=50/50-100/0 in 25 min, column 4*250 mm, 1.2 mL/min, detection at 254 nm) showed the presence of two colored substances: 17 with tR=10.7 min (58%) and 18 with tR=18.3 min (42%). This mixture was subjected to reverse-phase column chromatography (30 g of RP-SiO2, MeCN/H2O 2:1+0.1 v/v % of TFA?MeCN+0.1 v/v % of TFA?MeOH) to yield 8 mg (10%) of 17 and 7 mg (12%) of 18. Compound 17: .MS (ESI): m/z (positive mode, rel. int., %)=548.3 (100) [M-Cl]+. HRMS (C32H43N3O3P): m/z (positive mode)=548.3046 (found [M-Cl]+), 548.3037 (calc.). UV/Vis (MeCN): lambdamax (epsilon)=649 nm (52455 M-1cm-1); fluorescence (MeCN): lambdaexcit=610 nm, lambdaem=679 nm, phifl=0.25. Standard: Oxazine 1, phifl=0.11 (EtOH). UV/Vis (PBS 7.4): lambdamax (epsilon)=661 nm (46976 M-1cm-1); fluorescence (PBS 7.4): lambdaexcit=650 nm, lambdaem=696 nm, phifl=0.11. Standard: Atto 655, phifl=0.30 (H2O). Compound 18: .1H NMR (400 MHz, CDCl3): delta=1.94-2.02 (m, 4H, 2*CH2), 2.03-2.11 (m, 4H, 2*CH2), 2.84-2.90 (m, 4H, 2*CH2), 2.91-2.98 (m, 4H, 2*CH2), 3.43-3.52 (m, 8H, 4*CH2), 3.59 (d, JH-P=11.5 Hz, 3H, OMe), 8.95 (s, 2Har) ppm. 31P NMR (162 MHz, CD3CN): delta=5.0 ppm. UV/Vis (MeCN): lambdamax (epsilon)=596 nm (49565 M-1cm-1); fluorescence (MeCN): lambdaexcit=580 nm, lambdaem=623 nm, phifl=0.85. Standard: Atto 590, phifl=0.80 (H2O). UV/Vis (PBS 7.4): lambdamax (epsilon)=630 nm (52286 M-1cm-1); fluorescence (PBS 7.4): lambdaexcit=620 nm, lambdaem=666 nm, phifl=0.17. Standard: Atto 637, CDfl=0.25 (H2O). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In acetonitrile; at 60℃; for 2.5h;Inert atmosphere; | In a screw-cap test tube to a suspension of the corresponding pyronine (50 mg; 0.13 mmol) in MeCN (1 mL) <strong>[122194-07-4]dimethyl N,N-diisopropylphosphoramidite</strong> (100 mg; 0.52 mmol) was added at r.t. under Ar. The resulting reaction mixture was warmed up to 60 C. and stirred for 2.5 h at this temperature. After cooling down to 0 C., DDQ (116 mg; 0.52 mmol) was added, and the reaction mixture was stirred for additional 10 min at 0 C. After warming up to r.t., the reaction mixture was diluted with MeCN (10 ml) and directly subjected to column chromatography on SiO2 (100 g; MeCN?MeCN/H2O 20:1+0.1 v/v % of TFA). Fractions containing the title compound were evaporated to dryness, dissolved in water and extracted with CH2Cl2 (3*). Combined organic solutions were dried with Na2SO4 and evaporated to yield 40 mg of a dark blue solid. HPLC analysis (B/A=50/50-100/0 in 25 min, column 4*250 mm, 1.2 mL/min, detection at 254 nm) showed the presence of two colored substances: 17 with tR=10.7 min (58%) and 18 with tR=18.3 min (42%). This mixture was subjected to reverse-phase column chromatography (30 g of RP-SiO2, MeCN/H2O 2:1+0.1 v/v % of TFA?MeCN+0.1 v/v % of TFA?MeOH) to yield 8 mg (10%) of 17 and 7 mg (12%) of 18. Compound 17: .MS (ESI): m/z (positive mode, rel. int., %)=548.3 (100) [M-Cl]+. HRMS (C32H43N3O3P): m/z (positive mode)=548.3046 (found [M-Cl]+), 548.3037 (calc.). UV/Vis (MeCN): lambdamax (epsilon)=649 nm (52455 M-1cm-1); fluorescence (MeCN): lambdaexcit=610 nm, lambdaem=679 nm, phifl=0.25. Standard: Oxazine 1, phifl=0.11 (EtOH). UV/Vis (PBS 7.4): lambdamax (epsilon)=661 nm (46976 M-1cm-1); fluorescence (PBS 7.4): lambdaexcit=650 nm, lambdaem=696 nm, phifl=0.11. Standard: Atto 655, phifl=0.30 (H2O). Compound 18: .1H NMR (400 MHz, CDCl3): delta=1.94-2.02 (m, 4H, 2*CH2), 2.03-2.11 (m, 4H, 2*CH2), 2.84-2.90 (m, 4H, 2*CH2), 2.91-2.98 (m, 4H, 2*CH2), 3.43-3.52 (m, 8H, 4*CH2), 3.59 (d, JH-P=11.5 Hz, 3H, OMe), 8.95 (s, 2Har) ppm. 31P NMR (162 MHz, CD3CN): delta=5.0 ppm. UV/Vis (MeCN): lambdamax (epsilon)=596 nm (49565 M-1cm-1); fluorescence (MeCN): lambdaexcit=580 nm, lambdaem=623 nm, phifl=0.85. Standard: Atto 590, phifl=0.80 (H2O). UV/Vis (PBS 7.4): lambdamax (epsilon)=630 nm (52286 M-1cm-1); fluorescence (PBS 7.4): lambdaexcit=620 nm, lambdaem=666 nm, phifl=0.17. Standard: Atto 637, CDfl=0.25 (H2O). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With 2H-tetrazole; In dichloromethane; acetonitrile; at 20℃; for 1h;Inert atmosphere; | To a solution of allyl 4-hydroxybutyrate (100 mg; 0.69 mmol) in CH2Cl2 (7 mL) a solution of tetrazole (0.45 M; 6.4 mL; 2.89 mmol) in MeCN and dimethyl N,N-diisopropylphosphorimidate (306 mg; 1.59 mmol) were added under Ar. The reaction mixture was stirred for 1 h at r.t., and then sat. aq. NaHCO3 was added (?10 mL). The organic layer was separated, and the aq. layer was extracted with CH2Cl2 (2*). Combined organic solutions were dried with Na2SO4 and evaporated. The residue was subjected to column chromatography (10 g of SiO2, hexane/EtOAc 6:1) to yield 103 mg (63%) of colorless oil. 1H NMR (400 MHz, CD3CN): delta=1.84-1.92 (m, 2H, CH2), 2.42 (t, JH-H=7.3 Hz, 2H, CH2), 3.47 (d, JH-P=10.6 Hz, 6H, 2*OMe), 3.81 (dt, JH-P=7.5 Hz, JH-H=6.3 Hz, 2H, OCH2), 4.56 (dt, JH-H=5.5 and 1.5 Hz, 2H, OAll), 5.22 (m, JH-H=10.5 and 1.4 Hz, 1H, OAll), 5.31 (m, JH-H=17.3 and 1.6 Hz, 1H, OAll), 5.95 (m, JH-H=17.3, 10.5 and 5.5 Hz, 1H, OAll) ppm. 31P NMR (162 MHz, CD3CN): delta=140.1 ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
160 mg | With 2H-tetrazole; lithium chloride; In dichloromethane; at 20℃; for 72h;Molecular sieve; | To a solution of compound 12j (607 mg, 0.619 mmol), 1H-tetrazole (1.03 1 mL, 0.464 mmol), LiC1 (13 1.162 mg, 3.094 mmol) and 4A MS in DCM (68 mL) was added <strong>[122194-07-4]dimethyl diisopropylphosphoramidite</strong> (125.54 mg, 0.650 mmol). After stirring at rt for 72 h, themixture was filtered and purified by prep-HPLC (column: Phenomenex Gemini C 18250* 50 lOu; mobile phase: water (10mM NH4HCO3)-ACN from 28 % to 58 %, flow rate:22 mL/min) to afford compound 12k as a white solid (160 mg). ESI-MS: m/z 978.2[M+lfb; ?H NIVIR (400MHz, CD3OD) 8.81 (s, 1H), 8.30 - 8.21 (m, 3H), 8.06 (s, 1H), 7.75- 7.65 (m, 3H), 6.53 (d, J 17.2 Hz, 1H), 6.24 (d, J= 8.4 Hz, 1H), 5.46 - 5.28 (m, 1H),5.08 - 4.97 (m, 1H), 5.02 (dt, J 3.8, 8.4 Hz, 1H), 4.76 (d, J= 3.2 Hz, 1H), 4.51 - 4.36 (m,2H), 4.29-4.18 (m, 1H), 3.86 (d, J= 11.2 Hz, 3H), 2.80-2.69 (m, 1H), 1.28- 1.24 (m,6H), 1.00 (s, 9H), 0.32 (s, 3H), 0.27 - 0.24 (m, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Compound 18d (570 mg, 0.581 mmol) was co-evaporated with anhydrous toluene (2 x 20 mL) and dissolved in anhydrous CH3CN (10 mL). 4A molecular sieves powder (2 g)and tetrazole (8 mL, 3.48 mmol, 0.45 M in CH3CN) were added, and Ar(g) was bubbled into the reaction mixture for 2 mm, then allowed to stir for 10 mm at rt. Dimethyl-N,Ndiisopropylphosphoramidite (0.3 mL, 1.16 mmol) was added. After stirring the reaction mixture for 1 h at rt, the reaction mixture was filtered, and the filtrate was diluted withEtOAc (150 mL), then washed sequentially with sat. aq. NaHCO3 (1 x 30 mL) and sat. aq.NaC1 (1 x 30 mL). The organic phase was dried over Mg504 (stirring for 10 mm), filtered, and the filtrate concentrated to dryness under reduced pressure. The crude compound 18e was used in the next step without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
495 mg | With 2H-tetrazole; lithium chloride; In dichloromethane; at 20℃; for 72h;Molecular sieve; | To a solution of 20d (500 mg, 0.56 mmol) in DCM (60 mL) was added 4A Molecular Sieves (5 g), 1H-tetrazole (0.93 mL, 0.42 mmol) , LiC1 (118.18 mg, 2.79 mmol) followed by <strong>[122194-07-4]dimethyl diisopropylphosphoramidite</strong> (113.12 mg, 0.58 mmol). After stirring the reaction mixture for 72 h at room temperature, the mixture was filtered and concentrated under reduced pressure to get crude 20e (495 mg) which was used directly into the nextstep without further purification. ESI-MS: m/z 947.3 [M+1]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 2H-tetrazole; lithium chloride; In dichloromethane; acetonitrile; at 20℃; for 72h;Molecular sieve; | To a solution of compound 23i (470 mg,0.39 mmol), 1H-tetrazole (0.66 mL,0.3 mmol, 0.45M in CH3CN), LiC1 (84.23 mg,1.98 mmol) and 4A molecular sieves (2 g) in DCM (60 mL) was added <strong>[122194-07-4]dimethyl N,N-diisopropylphosphoramidite</strong> (94.50 mg, 0.48 mmol). The reaction mixture was stirred for 72 h at room temperature, filtered and concentrated underreduced pressure to give 23j (400 mg, crude product) as a white solid which was used directly for the next step without any further purification. ESI-MS: m/z=93 1.1 [M+1 ] |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
40%; 10% | With 1H-tetrazole; In dichloromethane; acetonitrile; at 20℃; for 7h; | To a solution ofazido alcohol 5 (100 mg, 0.662 mmol) and phosphorimidite 15 (0.19 mL, 0.993 mmol, 1.5 equiv)in 4 mL of anhydrous DCM was added 1.5 equiv of tetrazole (2.1 mL 0.47 M solution inacetonitrile, 0.993 mmol). After the solution was stirred at rt for 7h, it was then diluted with DCM,washed with 20 mL of 10% sodium bicarbonate solution and two 20 mL-portions of brine water,dried with Na2SO4, and concentrated under vacuum. Column chromatography of the residue gave16 as a white solid (55 mg, 40%) and 17 as colorless syrup (15 mg, 10%).16. 1H NMR (CDCl3, 300 MHz): delta 7.39-7.14 (m, 4 H), 5.24-5.08 (m, 2 H), 4.33 (ddd, J = 24.1,15.7, 12.1 Hz, 1 H), 3.99 (ddd, J = 43.0, 24.1, 8.3 Hz, 1 H), 3.85 (d, J =16.5 Hz, 3 H), 3.50-3.30(m, 1 H). HR-FABMS: calcd for C9H13NO3P (M + H)+ 214.0633, found 214.0649. 17. 1H NMR (CDCl3, 300 MHz): delta 8.03 (s, H), 7.52-7.35 (m, 4 H), 5.68 (s, H), 5.24-5.14(dd,2 H), 4.48 (s, 2 H), delta 3.75 (d, J = 4.1 Hz, 3/2 H), 3.71 (d, J = 4.1 Hz, 3/2 H). HR-FABMS: calcdfor C9H13N3O3P (M + H)+ 242.0694, found 242.0712. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21% | With 1H-tetrazole; In dichloromethane; acetonitrile; at 20℃; | General procedure: To the solution of an azido alcohol (0.853mmol) and phosphorimidite 15 (1.279 mmol, 1.5 equiv) in 4 mL of anhydrous DCM was added1.5 equiv of tetrazole (2.8 mL, 0.47 M solution in acetonitrile, 0.993 mmol). The solution wasstirred at rt for 1~16 h and then diluted with DCM, washed with 20 mL of 10% sodium bicarbonatesolution and two 20 Ml-portions of brine water, dried with Na2SO4, and finally concentrated undervacuum. Column chromatography of the residue gave the following products.2-Methyloxy-2-oxo-7,7-dimethyl-3,6,7,8-tetrahydro-1,3,4,5,2-oxtriazaphosphocine (18) ascolorless syrup, 21%. 1H NMR (CDCl3, 200 MHz): delta 8.56 (s, H), 5.06(s, H), 3.84-3.76 (m, 5H), 3.23 (s, 2 H), 0.97 (s, 6 H). HR-FABMS: calcd for C6H15N3O3P (M+ + H) 208.0851, found208.0865. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | With 1H-tetrazole; In dichloromethane; acetonitrile; at 20℃; | General procedure: To the solution of an azido alcohol (0.853mmol) and phosphorimidite 15 (1.279 mmol, 1.5 equiv) in 4 mL of anhydrous DCM was added1.5 equiv of tetrazole (2.8 mL, 0.47 M solution in acetonitrile, 0.993 mmol). The solution wasstirred at rt for 1~16 h and then diluted with DCM, washed with 20 mL of 10% sodium bicarbonatesolution and two 20 Ml-portions of brine water, dried with Na2SO4, and finally concentrated undervacuum. Column chromatography of the residue gave the following products.2-Methyloxy-2-oxo-7,7-dimethyl-3,6,7,8-tetrahydro-1,3,4,5,2-oxtriazaphosphocine (18) ascolorless syrup, 21%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | General procedure: To the solution of an azido alcohol(1 mmol) and 1.2 equiv of dibenzyl N,N-diisopropylphosphorimidite 4 in 5 mL of anhydrousdichloromethane (DCM) was added 1.2 equiv of tetrazole (0.47 M solution in acetonitrile). Afterthe solution was stirred at room temperature (rt) for 30 min, the temperature was lowered to -40 Cand 1.3 equiv of m-CPBA in 2 mL of DCM was added in one portion. This solution was stirredfor at the temerature 30 minutes, diluted with DCM, and washed with two 20 mL-portions of 10%sodium bicarbonate solution and 20 mL of brine water, dried with Na2SO4, and concentrated undervacuum. Column chromatography of the residue gave the product as described below. 2-(Azidomethyl)benzyl dibenzyl phosphate (6) as colorless syrup, 75%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
21%; 30% | With 1H-tetrazole; In dichloromethane; acetonitrile; at 20℃; for 10h; | To a solution of azido alcohol 23 (100mg, 0.662 mmol) and phosphorimidite 15 (0.19 mL, 0.993 mmol, 1.5 equiv) in 4 mL of anhydrousDCM was added 1.5 equiv of tetrazole (2.1 mL, 0.47 M solution in acetonitrile, 0.993 mmol). Thesolution was stirred at rt for 10 h and was then diluted with DCM, washed with 20 mL 10% sodiumbicarbonate solution and two 20 mL-portions of brine water, dried with Na2SO4, and concentratedunder vacuum. Column chromatography of the residue produced 26 (48 mg, 30%) and 27 (32 mg,21%), both as colorless syrup.26. 1H NMR (CDCl3, 300 MHz): delta 8.07 (d, J = 34.1 Hz, H), 7.50-7.32 (m, 5 H), 5.68 (d, J =34.1 Hz, H), 5.60-5.47 (m, 1 H), 3.79 (d, J = 11.0 Hz, 3/2 H), 3.72-3.47 (m, 2 H), 3.58 (d, J =11.0 Hz, 3/2 H). HR-FABMS: calcd for C9H13N3O3P (M + H)+ 242.0695, found 242.0702.27. 1H NMR (CDCl3, 300 MHz): delta 7.43-7.24 (m, 5 H), 3.84 (d, J = 10.8 Hz, 3 H), 3.79 (d, J = 10.8Hz, 3 H), 3.53 (ddd, J = 15.8, 6.1, 3.4 Hz, 1 H), 2.72 (ddd, J = 18.3, 6.1, 1.6 Hz, 1 H), 2.20 (ddd, J =14.8, 3.4, 1.6 Hz, 1 H). HR-FABMS: calcd for C10H15NO3P (M + H)+ 228.0790, found 228.0794. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
10% | With 1H-tetrazole; In dichloromethane; acetonitrile; at 20℃; | General procedure: To the solution of an azido alcohol (0.853mmol) and phosphorimidite 15 (1.279 mmol, 1.5 equiv) in 4 mL of anhydrous DCM was added1.5 equiv of tetrazole (2.8 mL, 0.47 M solution in acetonitrile, 0.993 mmol). The solution wasstirred at rt for 1~16 h and then diluted with DCM, washed with 20 mL of 10% sodium bicarbonatesolution and two 20 Ml-portions of brine water, dried with Na2SO4, and finally concentrated undervacuum. Column chromatography of the residue gave the following products.2-Methyloxy-2-oxo-7,7-dimethyl-3,6,7,8-tetrahydro-1,3,4,5,2-oxtriazaphosphocine (18) ascolorless syrup, 21%. |
Tags: 122194-07-4 synthesis path| 122194-07-4 SDS| 122194-07-4 COA| 122194-07-4 purity| 122194-07-4 application| 122194-07-4 NMR| 122194-07-4 COA| 122194-07-4 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :